Optimal surgical treatment of invasive lobular carcinoma of the breast

Annals of Surgical Oncology

Volumn 4, Issue 7, 1997, Pages 545-550

  Chung, Maureen A ^a   Cole, Bernard ^b   Wanebo, Harold J ^a   Bland, Kirby I ^b   Chang, Helena R ^a,c  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

Breast; Lobular carcinoma; Surgical treatment

Indexed keywords

BREAST TUMOR; CANCER INVASION; FEMALE; FOLLOW UP; HUMAN; LUNG CARCINOMA; LYMPHADENECTOMY; MASTECTOMY; MORTALITY; PATHOLOGY; REVIEW; SEGMENTAL MASTECTOMY; SURVIVAL RATE; TIME; TUMOR RECURRENCE;

BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; TIME FACTORS;

EID: 0031241362     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02305534     Document Type: Article

References (24)

1. Parker SL, Tonga T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
2. Kinne DW. Controversies in primary breast cancer management. Am J Surg 1993;166:502-8.
3. Fisher B, Redmond C, Poisson R, et al. Eight year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320:822-8.
4. Foote FW, Stewart FW. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Path 1941;17:491-5.
5. Muir R. The evolution of carcinoma of the mammae. J Path Bacteriol 1941;52:155-72.
6. Winchester DJ, Chang HR, Graves TA, Menck HR, Bland KI, Winchester DP. A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment and outcome. Ann Surg Oncol (in press).
7. Le Gal M, Ollivier L, Asselain B, Meunier M, Laurent M, Vieth P, Neuenschwander S. Mammographic features of 455 invasive lobular carcinomas. Radiology 1992;185:705-8.
8. Krecke KN, Gisvold JJ. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR 1993;161:957-60.
9. Yeatman TJ, Cantor AB, Smith TJ, et al. Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 1995;222:549-61.
10. Shnitt SJ, Connolly JL, Recht A, Silver B, Harris JR. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 1989;64:448-54.
11. Kurtz JM, Jacquemier J, Torhorst J, et al. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 1989;63:1630-5.
12. du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Robertson JFR, Blamey RW. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol 1991;17:251-7.
13. Poen JC, Tran L, Juillard G, et al. Conservation therapy for invasive lobular carcinoma of the breast. Cancer 1992;69:2789-95.
14. Weiss MC, Fowble BL, Solin LJ, Yeh IT, Schultz DJ. Outcome of conservative therapy for invasive breast cancer by histologic type. Int J Radiation Oncology Biol Phys 1992;23:941-7.
15. White JR, Gustafson GS, Wimbish KW, et al. Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. The role of preoperative mammograms in guiding treatment. Cancer 1994;74:640-7.
16. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Can Inst 1995;87:19-27.
17. Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996;77:113-20.
18. Salvadori B, Biganzoli E, Veronesi P, Sacozzi R, Rilke F. Conservative surgery for infiltrating breast carcinoma. Br J Surg 1997; 84:106-9.
19. Wanebo HJ, Senofsky GM, Fechner RE, Kaiser D, Lynn S, Paradies J. Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg 1985;201:667-77.
20. Silverstein MJ, Lewinsky BS, Waisman JR, et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 1994;73:1673-7.
21. Broet P, de la Rochefordiere A, Scholl S, et al. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol 1995; 13:1578-83.
22. Healey EA, Cook EF, Orav EJ, Schnitt SJ, Connolly JL, Harris JR. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol 1993;11:1545-52.
23. Smith BL, Bertagnolli M, Klein BB, Batter S, Chang H, Douville LM, Eberlein TJ. Evaluation of the contralateral breast. The role of biopsy at the time of treatment. Ann Surg 1992;216:17-21.
24. Singletary SE, Taylor SH, Guinee VF, Whitworth PW. Occurrence and prognosis of contralateral carcinoma of the breast. J Am Coll Surg 1994;178:390-6.